Endocrinology 154: 4-8, 2013
McDonough, A.A., Youn, J.H
Deborah Ekstrom are helping patients navigate the growing field of post-weight-loss body contouring combining advanced liposuction techniques with skin-tightening technologies to deliver results that medication alone cannot achieve
Plaintiffs correctly say those claims are baseless
Additionally, GLP-1 agonism directly influences insulin secretion and response
Tirzepatide titration may continue as follows: Week 8: 7.5 mg weekly (if 5 mg was well-tolerated) Week 12: 10 mg weekly (for patients who need additional appetite suppression) Week 16: Up to 12.5 mg or 15 mg (maximum doses, used selectively) Ipamorelin adjustments: If well-tolerated at 200 mcg, may increase to 250 to 300 mcg daily Some physicians add a second daily dose (morning, fasted) for enhanced GH support If water retention or joint stiffness develops, dose may be reduced Labs at the 8-week mark should include IGF-1, thorough metabolic panel, HbA1c, and lipids